Pessac, France · Founded 2018 · Privately Held (backing)
Developer of a proprietary technology platform designed to provide alternative access to cell therapies. Treefrog Therapeutics is based in Pessac, France and was founded in 2018. It has raised $116 million.
Last price · $/share
—
Implied valuation
—
Total raised
$116.1M
Last round
—
Cap table — not yet on record
Treefrog Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Treefrog Therapeutics with a free account
·The complete investor list: 21 names
·Watch Treefrog Therapeutics: the Monday email on marks, rounds and moves
